首页> 外文期刊>Theranostics >Serum Immune Profiling for Early Detection of Cervical Disease
【24h】

Serum Immune Profiling for Early Detection of Cervical Disease

机译:血清免疫分析法可早期发现宫颈疾病

获取原文
       

摘要

Background: The most recent (2012) worldwide estimates from International Agency for Research on Cancer indicate that approximately 528,000 new cases and 270,000 deaths per year are attributed to cervical cancer worldwide. The disease is preventable with HPV vaccination and with early detection and treatment of pre-invasive cervical intraepithelial neoplasia, CIN. Antibodies (Abs) to HPV proteins are under investigation as potential biomarkers for early detection.
机译:背景:国际癌症研究机构的最新(2012年)全球估计表明,全球每年约有528,000例新病例和270,000例死亡归因于宫颈癌。通过HPV疫苗接种以及浸润前宫颈上皮内瘤变CIN的早期发现和治疗,可以预防该病。目前正在研究针对HPV蛋白的抗体(Abs),作为早期检测的潜在生物标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号